by Elizabeth Story, MD | Oct 21, 2025 | Blog
GLP-1 receptor agonists like semaglutide and tirzepatide have revolutionized weight loss and diabetes care. But a growing number of patients and clinicians are exploring microdosing—taking a fraction of the standard dose—to unlock broader health benefits with fewer...
by Elizabeth Story, MD | Jul 15, 2025 | Blog
If you follow my posts on social media, you already know that I encourage my patients to research the benefits of weight loss “drugs.” Although they can be controversial, the evidence is mounting in terms of the ground-breaking solution these medications provide for...
by Elizabeth Story, MD | May 8, 2024 | News
There are so many questions brought about by the news media in regards to health. And now so many are related to the GLP-1 medications such as Ozempic and Mounjaro. One of the focuses of the regular blog will be to address much of the confusion and questions generated...
